The IPO Buzz: BETA Technologies’ IPO Tops Early November Calendar of $1.5B

BETA Technologies (BETA Proposed), an electric plane manufacturer, leads the IPO Calendar as November gets under way – and the U.S. government shutdown starts its fifth week.  BETA Technologies’ $750 million IPO represents half of the $1.5 billion that bankers expect to raise by pricing five large deals this week.

Flight is in play. Grupo Aeromexico (AERO Proposed) is on the IPO runway with its $222.8 million IPO.

The insurance and healthcare sectors are in the mix. Exzeo (XZO Proposed), a property and casualty (P&C) insurance platform, expects to raise about $168 million. BillionToOne (BLLN Proposed), a pioneer in prenatal diagnostic testing for sickle cell disease (SCD) and cystic fibrosis (CF), intends to raise $200 million. Evommune (EVMN Proposed), a Phase 2 biotech developing drugs to treat atopic dermatitis and Crohn’s disease,  plans to raise $150 million.

Four of the five big IPOs on this week’s IPO Calendar are New York Stock Exchange listings. BillionToOne (BLLN Proposed) is the only large NASDAQ deal in the line-up.

Stay tuned.

(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.) 

Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. 

To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. 

Disclosure: Nobody on the IPOScoop.comstaff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.

Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading.